Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
24 hedge funds and large institutions have $3.12M invested in Vaccinex, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
37% more capital invested
Capital invested by funds: $2.28M → $3.12M (+$833K)
9% more funds holding
Funds holding: 22 → 24 (+2)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$218K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.24K |
| 3 |
BlackRock
New York
|
+$620 |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$372 |
| 5 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$124 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$54.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$51.8K |
| 3 |
TI
Telemetry Investments
New York
|
-$43.6K |
| 4 |
Millennium Management
New York
|
-$19.3K |
| 5 |
VF
Virtu Financial
New York
|
-$5K |
VCNX Hedge Fund Activity: Q4 2022 in Review
24 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q4 2022, worth a combined $3.12M — up 37% from $2.28M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new VCNX positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 7 trimmed.
The largest buyer was AIGH Capital Management, adding an estimated $218K. The largest seller was Citadel Advisors, cutting an estimated $54.7K.
- 24 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q4 2022, up from 22 in Q3 2022.
- Funds reported $3.12M of Vaccinex, Inc. Common Stock stock for Q4 2022, up 37% quarter-over-quarter.
- 4 funds opened new Vaccinex, Inc. Common Stock positions in Q4 2022 and 2 closed out, a net change of +2 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q4 2022 was AIGH Capital Management, an estimated $218K added.
- The largest Vaccinex, Inc. Common Stock seller in Q4 2022 was Citadel Advisors, an estimated $54.7K sold.
Based on aggregated 13F filings for Q4 2022.